2018
DOI: 10.1016/s1473-3099(18)30233-0
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy and tolerability of moxidectin alone and in co-administration with albendazole and tribendimidine versus albendazole plus oxantel pamoate against Trichuris trichiura infections: a randomised, non-inferiority, single-blind trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
34
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
4
3

Relationship

2
5

Authors

Journals

citations
Cited by 34 publications
(37 citation statements)
references
References 26 publications
3
34
0
Order By: Relevance
“…Efficacy (cure rates and egg reduction rates) of the four treatment arms based on KK were presented elsewhere [21]. In the framework of this study we compare cure rates obtained with PCR and KK for a subset of patients (Table 4).…”
Section: Cure Rates According To Kato-katz and Pcrmentioning
confidence: 99%
See 2 more Smart Citations
“…Efficacy (cure rates and egg reduction rates) of the four treatment arms based on KK were presented elsewhere [21]. In the framework of this study we compare cure rates obtained with PCR and KK for a subset of patients (Table 4).…”
Section: Cure Rates According To Kato-katz and Pcrmentioning
confidence: 99%
“…Stool samples were collected in the framework of a phase II, randomized, single-blind clinical trial evaluating the safety and efficacy of moxidectin alone and in co-administration with albendazole and tribendimidine versus albendazole-oxantel pamoate co-administration against T. trichiura infection [21]. The trial was performed between April and August 2017 on Pemba Island, United Republic of Tanzania in school-aged adolescents (12-19 years old).…”
Section: Study Design and Laboratory Proceduresmentioning
confidence: 99%
See 1 more Smart Citation
“…Although the treatment of onchocerciasis was previously restricted to the use of ivermectin, the US Food and Drug Administration recently approved the drug moxidectin, which is a macrocyclic lactone milbemycin antibiotic approved for the treatment of onchocerciasis in patients aged 12 years and older . Moxidectin also works to inhibit glutamate‐gated chloride channels in microfilariae.…”
Section: Treatmentmentioning
confidence: 99%
“…Similar to ivermectin, the adverse effects of moxidectin are a result of immunologic response to the increased load of dead microfilariae within 48 hours of administration. Moxidectin may be given alone and in coadministration with the benzimidazole anthelmintic, albendazole . Another benzimidazole anthelmintic, flubendazole, has also been encouraged as a macrofilaricide …”
Section: Treatmentmentioning
confidence: 99%